Hengrui, Affiliate Reistone In Apparent Dispute Over China Ivarmacitinib NDAs

Promises, Perils Of A Seemingly Dream Partnership

 
• By Brian Yang
  
Jiangsu Hengrui Medicine
Hengrui and affiliate Reistone at loggerheads over NDA strategy? • Source: Shutterstock

More from China

More from Focus On Asia